PLSE Pulse Biosciences, Inc.
Healthcare$25.89+1.29%ClosedMarket Cap: $1.79B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
26.47
P/S
2385.94
EV/EBITDA
-23.46
DCF Value
$1.06
FCF Yield
-3.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
-91.1%
Operating Margin
-10392.1%
Net Margin
-9929.0%
ROE
-86.7%
ROA
-91.4%
ROIC
-106.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $401.0K | 7.7% | $-19.1M | $-18.6M | $— | — |
| Q4 null | $264.0K | -96.6% | $-18.3M | $-17.4M | $— | — |
| FY null | $350.0K | -360.0% | $-76.9M | $-72.8M | $— | — |
| Q3 null | $86.0K | -224.4% | $-20.4M | $-19.4M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-20.3M | $-19.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-18.0M | $-16.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-20.3M | $-19.4M | $— | — |
| FY null | $0.00 | NaN% | $-56.3M | $-53.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-13.7M | $-12.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-11.7M | $-11.4M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-10.6M | $-10.1M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-12.5M | $-11.9M | $-0.22 | — |